DYSLIPIDEMIA IN ELDERLY PATIENTS WITH CEREBROVASCULAR ACCIDENTS: A CROSS-SECTIONAL STUDY.
DOI:
https://doi.org/10.51168/sjhrafrica.v5i12.1435Keywords:
Dyslipidemia, Elderly, Cerebrovascular Accident, Hypertension, Diabetes, Lipid ManagementAbstract
Background
Dyslipidemia is a significant risk factor for cerebrovascular accidents (CVA), especially among the elderly, due to age-related metabolic changes. This demographic is more vulnerable to lipid abnormalities, which increase the risk and severity of ischemic strokes. Despite established guidelines, dyslipidemia remains poorly controlled in elderly populations, underlining the need for targeted lipid management. This study aimed to examine the prevalence of dyslipidemia in elderly CVA patients.
Methods
A study was conducted at MGM Institute of Health Sciences, Navi Mumbai, over 1.5 years, involving 150 elderly CVA patients. Participants underwent lipid profile assessments, and data were collected on demographic, clinical, and lifestyle factors. Statistical analyses were performed using SPSS version 22.0, with chi-square tests and logistic regression applied to determine associations between dyslipidemia and risk factors.
Results
Of the 150 participants, 74.7% had dyslipidemia, with high LDL levels in 60% and low HDL levels in 70.7% of cases. Dyslipidemia was significantly associated with hypertension (OR 2.58, p < 0.01) and diabetes (OR 1.98, p = 0.02). Patients with severe CVA had significantly higher LDL and total cholesterol levels than those with milder CVA presentations (p < 0.05).
Conclusion
The study reveals a high prevalence of dyslipidemia in elderly CVA patients, particularly among those with hypertension and diabetes. Dyslipidemia is associated with increased CVA severity, suggesting that lipid abnormalities may exacerbate stroke outcomes in elderly individuals.
Recommendations
Regular lipid screenings and targeted lipid management should be prioritized in elderly patients with CVA, especially those with hypertension and diabetes. Implementing effective lipid management strategies may reduce morbidity and improve outcomes in this high-risk population.
References
Fiore V, Barucca A, Barraco S, Triggiani D, Tragni D, Piazzolla G, Triggiani V, Carbotta G, Lisco G. Dyslipidemia and cardiovascular prevention in the elderly: a balance between benefits and risks of statin treatment in a specific population. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2023 Sep 1;23(11):1371-9.
https://doi.org/10.2174/1871530323666230428092828
PMid:37132306
Lind L, Sundström J, Ärnlöv J, Risérus U, Lampa E. A longitudinal study over 40 years to study the metabolic syndrome as a risk factor for cardiovascular diseases. Scientific Reports. 2021 Feb 3;11(1):2978.
https://doi.org/10.1038/s41598-021-82398-8
PMid:33536506 PMCid:PMC7858618
Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Dyslipidemia as a risk factor for ischemic stroke. Current topics in medicinal chemistry. 2009 Oct 1;9(14):1291-7.
https://doi.org/10.2174/156802609789869628
PMid:19849661
Cho L, Davis M, Elgendy I, Epps K, Lindley KJ, Mehta PK, Michos ED, Minissian M, Pepine C, Vaccarino V, Volgman AS. Summary of updated recommendations for primary prevention of cardiovascular disease in women: JACC state-of-the-art review. Journal of the American college of cardiology. 2020 May 26;75(20):2602-18.
https://doi.org/10.1016/j.jacc.2020.03.060
PMid:32439010 PMCid:PMC8328156
Cao S, Teng L, Gao M, Hu S, Xiao S, Chen C, He Y, Cheng S, Xie X. Nonlinear relationship between triglycerides and cognitive function after acute ischemic stroke among older adults. Heliyon. 2024 Mar 30;10(6).
https://doi.org/10.1016/j.heliyon.2024.e27943
PMid:38524625 PMCid:PMC10958424
Karantas ID, Okur ME, Okur NÜ, Siafaka PI. Dyslipidemia management in 2020: an update on diagnosis and therapeutic perspectives. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2021 May 1;21(5):815-34.
https://doi.org/10.2174/1871530320666200810144004
PMid:32778041
Jian-Jun LI, Shui-Ping ZH, Dong ZH, Guo-Ping LU, Dao-Quan PE, Jing LI, Zhen-Yue CH, Yuan-Lin GU, Na-Qiong WU, Sheng-Kai YA, Zeng-Wu WA. 2023 China guidelines for lipid management. Journal of Geriatric Cardiology: JGC. 2023 Sep 9;20(9):621.
https://doi.org/10.26599/1671-5411.2023.09.008
PMid:37840633 PMCid:PMC10568545
Ali I, Abuissa M, Alawneh A, Subeh O, Abu Sneineh A, Mousa S, Deeb I, Rayyan H. The prevalence of dyslipidemia and hyperglycemia among stroke patients: preliminary findings. Stroke research and treatment. 2019;2019(1):8194960.
https://doi.org/10.1155/2019/8194960
PMid:31781362 PMCid:PMC6875342
Ariyanti R, Imam CW. Diabetes Mellitus With Hypertension Increases The Risks For Chronic Kidney Disease: A Case-Control Study In Panti Nirmala Hospital, Malang. Jurnal kesehatan masyarakat. 2020;6(2):121-33.
https://doi.org/10.35329/jkesmas.v6i2.1876
Sah, D., Das, A. & Jana, D., 2021. Prospective Cross-Sectional Study of Incidence and Correlation of Dyslipidemia in Predicting Outcome of Patients Diagnosed with Cerebrovascular Accident at MMCH, Madhubani, Bihar. International Journal of Scientific Research, pp.33-34.
https://doi.org/10.36106/ijsr/1234431
Mohammedin AS, Horaib WS, Alshamsi RA, Alrashdi SO, Aleidi DA, Al Subaie MS, Jatoi NA. Assessment of Cerebrovascular Accident and Transient Ischemic Attack Risk Factors in Elderly vs. Non-Elderly Patients at a Tertiary Care Hospital in Eastern Province, Saudi Arabia. Cureus. 2021 Sep;13(9).
https://doi.org/10.7759/cureus.18391
Jaffar MU, Rafique AD, Khalid SI, Waheed SH. Frequen cy of Dyslipidemia in Ischemic Stroke Patients Presented to Tertiary Care Hospital of Lahore. Pak J Med Health Sci. 2021 Oct;15(10):3417-19.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Rachita Sinha, Bharat Dhareshwar, Sucheeth Avanti
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.